Olympus Corporation

About Olympus Corporation

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

Global homepage of Olympus Group. As a leading manufacturer of optical and digital precision technology, we provide innovative medical systems, scientific solutions around the world.

https://www.olympus-global.com

7733.T Japan

3,012USD1 (+0.03%)

• At close Fri Oct 07 2022

Tokyo exchange

Sector: Healthcare

Industry: Medical Instruments & Supplies

Location Japan, Tokyo

Grade: ABA

22,955,194,547 USD
MARKET CAP
19.760
PE
0.699
BETA (5y)
108.630
EPS

Profits

for 5 years
187%
for 3 years
69%
for 2 years
59%
for last year
18%
for this year
0%
Olympus Corporation
© 2025 avazzy.com. All rights reserved
Make with 🤎 and ☕ for you!

Investing involves risk, including possible loss of principal.

The strategies discussed are strictly for illustrative and educational purposes and are not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. There is no guarantee that any strategies discussed will be effective.

International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation and the possibility of substantial volatility due to adverse political, economic or other developments. These risks often are heightened for investments in emerging/ developing markets or in concentrations of single countries.